Nkarta, Inc. SEC filings NKTX
Nkarta, Inc. has 438 filings in SEC EDGAR's recent list, going back to Sep 6, 2019. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 3, 2026 | — |
| CORRESP | Letter to the SEC | Apr 1, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2026 | — |
| EFFECT | Filing | May 5, 2023 | — |
| CORRESP | Letter to the SEC | May 3, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2023 | — |
| EFFECT | Filing | Sep 2, 2021 | — |
| CORRESP | Letter to the SEC | Aug 31, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2021 | — |
| EFFECT | Filing | Jul 9, 2020 | — |
| CERT | 8a cert | Jul 9, 2020 | — |
| CORRESP | Letter to the SEC | Jul 8, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2020 | — |
| CORRESP | Letter to the SEC | Jul 7, 2020 | — |
| CORRESP | Letter to the SEC | Jul 7, 2020 | — |
| 8-A12B | Filing | Jul 2, 2020 | — |
| CORRESP | Letter to the SEC | Jul 2, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2020 | — |
| CORRESP | Letter to the SEC | Jun 29, 2020 | — |
| CORRESP | Letter to the SEC | Jun 19, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 1, 2020 | — |
| DRS/A | Filing | May 19, 2020 | — |
| DRSLTR | Filing | May 18, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2020 | — |
| DRS/A | Filing | Apr 20, 2020 | — |
| DRSLTR | Filing | Apr 17, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2020 | — |
| DRS | Filing | Feb 28, 2020 | — |
| DRSLTR | Filing | Feb 27, 2020 | — |
| D | Filing | Sep 6, 2019 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NKTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1787400
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.